MRK (more) Merck: signed non-exclusive voluntary licensing agreements with Aspen, quality chemical industries & ucl Kenya for alimatravir

MRK (more) Merck: signed non-exclusive voluntary licensing agreements with Aspen, quality chemical industries & ucl Kenya for alimatravir - Signed non-exclusive voluntary licensing agreements with aurobindo, cipla, emcure and Viatris for alimatravir - Announces initial access plans for alimatravir in low- and middle Income countries for prevention of hiv-1 - Voluntary licensing agreements for alimatravir cover 129 countries - In active discussions with fiocruz on alimatravir availability in Latin America & Brazil - Plans initial alimatravir supply pending regulatory approval, generic manufacturing ramp-up in licensed territories